ArticlePathogens (Basel, Switzerland)2026
Molecular Characterization of Measles and Rubella Virus Strains from the 2018-2019 Epidemic in Madagascar.
Article in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Madagascar experienced a severe measles epidemic between September 2018 and mid-2019, resulting in more than 146,000 cases and 1200 deaths, primarily among children under 15 years of age. This epidemic occurred in a context of low vaccination coverage. Prior to this outbreak, no genotyping data were available for the measles virus (MeV) or rubella virus (RuV) in Madagascar. This study aimed to molecularly characterize MeV and RuV strains circulating during the epidemic. A total of 310 biological samples (gingival swabs, urine, and stool) were collected from 288 suspected cases with a mean age of 11.4 years. Viral detection was performed using real-time RT-PCR, followed by conventional RT-PCR and sequencing of the N and H genes for MeV and of the E1 gene for RuV. Co-circulation of the two viruses was observed, with positivity rates of 39.9% (115/288) for MeV and 40.0% (70/175) for RuV. The mean age differed significantly between MeV-positive (12.0 years) and RuV-positive (7.2 years) patients, with 35.1% and 43.8% of cases occurring in children under five years of age, respectively. Phylogenetic analysis showed that all MeV strains belonged to genotype [B3], and they were highly similar to strains circulating globally in 2018-2019, suggesting recent introduction. In contrast, all RuV strains belonged to genotype [2B] and displayed greater genetic diversity, consistent with endemic rubella circulation in a partially vaccinated or unvaccinated population. This study provides the first genotyping data for Madagascar essential for monitoring virus circulation and supporting elimination efforts in the African region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.